Molecular imaging is a rapidly emerging biomedical discipline that allows the visualization, characterization, and quantification of biological processes at the cellular and subcellular levels in living organisms. It represents a significant shift from traditional imaging methods that rely on nonspecific macroscopic changes to specific molecular events, such as gene expression. This approach enables the understanding of integrative biology, earlier disease detection, and treatment evaluation. Molecular imaging combines multiple disciplines, including imaging technologies, basic biology, chemistry, medicine, and bioinformatics, to provide insights into physiological and pathological processes in a physiologically relevant context. Molecular imaging has roots in nuclear medicine and has evolved to include other modalities such as optical imaging, magnetic resonance imaging (MRI), and computed tomography (CT). It offers advantages over conventional in vitro and cell culture methods by providing noninvasive, real-time information about molecular processes in living subjects. This is particularly useful for studying transgenic and gene-targeted animal models, where phenotypic screening can be performed without killing the animals. Molecular imaging also allows for the monitoring of multiple molecular events simultaneously, tracking cell trafficking, optimizing drug and gene therapy, and assessing disease progression at a molecular level. The development of molecular imaging has been driven by advances in molecular and cell biology, the use of transgenic animal models, and the availability of specific imaging probes. These advancements have enabled the integration of in vitro and in vivo studies, leading to new insights into disease mechanisms and the development of molecular medicine. The field is further supported by the availability of small-animal imaging instrumentation, which allows for high-resolution imaging of biological processes in living subjects. Molecular imaging techniques include positron emission tomography (PET), optical imaging, and MRI. PET uses radioactive tracers to detect molecular events, while optical imaging employs bioluminescence and fluorescence to visualize molecular processes. MRI provides high-resolution anatomical and functional information, and CT offers high-resolution anatomical imaging. Each modality has its own strengths and limitations, with PET being highly sensitive for detecting low concentrations of molecular probes, optical imaging being useful for real-time monitoring, and MRI providing excellent soft-tissue contrast. Despite its advantages, molecular imaging faces challenges such as limited sensitivity, depth penetration, and the need for specialized equipment. However, ongoing advancements in imaging technology and probe development are expected to enhance the capabilities of molecular imaging, enabling more detailed and quantitative studies of biological processes in living subjects.Molecular imaging is a rapidly emerging biomedical discipline that allows the visualization, characterization, and quantification of biological processes at the cellular and subcellular levels in living organisms. It represents a significant shift from traditional imaging methods that rely on nonspecific macroscopic changes to specific molecular events, such as gene expression. This approach enables the understanding of integrative biology, earlier disease detection, and treatment evaluation. Molecular imaging combines multiple disciplines, including imaging technologies, basic biology, chemistry, medicine, and bioinformatics, to provide insights into physiological and pathological processes in a physiologically relevant context. Molecular imaging has roots in nuclear medicine and has evolved to include other modalities such as optical imaging, magnetic resonance imaging (MRI), and computed tomography (CT). It offers advantages over conventional in vitro and cell culture methods by providing noninvasive, real-time information about molecular processes in living subjects. This is particularly useful for studying transgenic and gene-targeted animal models, where phenotypic screening can be performed without killing the animals. Molecular imaging also allows for the monitoring of multiple molecular events simultaneously, tracking cell trafficking, optimizing drug and gene therapy, and assessing disease progression at a molecular level. The development of molecular imaging has been driven by advances in molecular and cell biology, the use of transgenic animal models, and the availability of specific imaging probes. These advancements have enabled the integration of in vitro and in vivo studies, leading to new insights into disease mechanisms and the development of molecular medicine. The field is further supported by the availability of small-animal imaging instrumentation, which allows for high-resolution imaging of biological processes in living subjects. Molecular imaging techniques include positron emission tomography (PET), optical imaging, and MRI. PET uses radioactive tracers to detect molecular events, while optical imaging employs bioluminescence and fluorescence to visualize molecular processes. MRI provides high-resolution anatomical and functional information, and CT offers high-resolution anatomical imaging. Each modality has its own strengths and limitations, with PET being highly sensitive for detecting low concentrations of molecular probes, optical imaging being useful for real-time monitoring, and MRI providing excellent soft-tissue contrast. Despite its advantages, molecular imaging faces challenges such as limited sensitivity, depth penetration, and the need for specialized equipment. However, ongoing advancements in imaging technology and probe development are expected to enhance the capabilities of molecular imaging, enabling more detailed and quantitative studies of biological processes in living subjects.